Control Bionics Ltd. (AU:CBL) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Control Bionics Ltd. announced a change in Director Damian Lismore’s indirect interest, with an acquisition of 42,380 ordinary shares and 79,286 options, bringing his total to 971,905 shares. This increase reflects the issuance of underwriting shares and options, valued at $2,966.60 for the shares acquired. Investors in Control Bionics may find this development significant as it demonstrates insider confidence in the company’s prospects.
For further insights into AU:CBL stock, check out TipRanks’ Stock Analysis page.